Since CD28−CD8+ T cells are present in the tumor microenvironment, it is conceivable that CD73-mediated adenosine production by CD28−CD8+ T cells suppresses CD8+ effector T cells to allow immune escape. This evidence concerns the gene CD8A and neoplasm.